Al-Maaden and Eccoit Sign Waste Contract
Reports have indicated that Pfizer has begun delivering new COVID-19 vaccines that include modifications to target new variants of the virus. This move responds to the importance of updating vaccines to combat emerging mutations. It comes as part of ongoing efforts to boost protection and reduce infection rates, with expectations that the modified vaccines will be widely available in the coming months, aiming to enhance immune effectiveness and the global response to the pandemic.
Size: 120%Text Size
Notice: This Is an AI-Generated Summary
Comments (0)